國立虎尾科技大學 |

Critical Issues in Head and Neck Oncology = Key Concepts from the Seventh THNO Meeting /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Critical Issues in Head and Neck Oncology/ edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O’Sullivan.
其他題名:	Key Concepts from the Seventh THNO Meeting /
其他作者:	O’Sullivan, Brian.
面頁冊數:	IX, 373 p. 39 illus., 33 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Surgical Oncology. -
電子資源:	https://doi.org/10.1007/978-3-030-63234-2
ISBN:	9783030632342

Critical Issues in Head and Neck Oncology = Key Concepts from the Seventh THNO Meeting /
Critical Issues in Head and Neck OncologyKey Concepts from the Seventh THNO Meeting /[electronic resource] :edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O’Sullivan. - 1st ed. 2021. - IX, 373 p. 39 illus., 33 illus. in color.online resource.

Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) -- Promising biomarkers for early diagnosis and prognosis prediction in HNS -- Biomarkers to predict radiotherapy toxicity -- Biomarkers for hypoxia, HPVness and proliferation from imaging perspective -- Mechanism of cetuximab resistance and how to overcome it -- The role of liquid biopsy for monitoring disease evolution -- NK cells in immunotherapy: how important are they? -- Biomarkers for immune modulatory treatment in HNSCC -- Primary disease (1) -- Novel approaches in surgical management of HNSCC -- The surgical approach to elderly patients with HNSCC -- The nonsurgical approach to locoregionally advanced HNSCC -- High-dose three-weekly or low-dose weekly cisplatin during radiation, what to prefer? -- Primary disease (2) -- Where and when to use induction chemotherapy? -- Prognostic role of p16/HPV in non-oropharyngeal head and neck cancer -- Is there a role for neoadjuvant targeted and immunotherapies? -- Is there a role for adjuvant targeted and immunotherapies? -- Optimal supportive measures during primary treatment -- Precision Medicine in head and neck cancer: myth or reality -- Recurrent and / or metastatic disease -- Salvage surgery: candidates, safe reconstruction, and results? -- Re-irradiation for local relapses or second primaries: when and how? -- New promising targeted agents in first and second-line settings -- Update of immune therapies in recurrent/metastatic HNSCC -- Special Issue -- Patients with rare head neck cancers: do they need a different approach? .-Nasopharynx cancer -- New epidemiological aspects -- New developments in the management of nasopharyngeal carcinoma -- New drugs for recurrent/metastatic nasopharynx cancer.

Open Access

This open access book discusses the most current issues in head and neck cancer with a focus on current trends such as biomarkers, precision medicine and immunotherapy. New approaches in the diagnosis such as liquid biopsies and imaging biomarkers to predict radiotherapy toxicity as well as approaches in the surgical management of head and neck cancers are discussed. The book discusses medical and surgical approaches in both primary, recurrent and metastatic disease and also covers approaches for rare head neck cancers. Readers will learn about the latest drug developments and epidemiological aspects in cancers ranging from head and neck squamous cell cancer to nasopharynx cancer. Edited by a team of world leaders in head and neck cancer, this volume serves as an easy reference to the head and neck oncology practitioner and provides a contemporary overview for specialists the field. The chapters are based on the latest data presented at the 7th Trends in Head and Neck Oncology Conference and reflect the most up-to-date information in the field.

ISBN: 9783030632342

Standard No.: 10.1007/978-3-030-63234-2doiSubjects--Topical Terms:

673742
Surgical Oncology.

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Critical Issues in Head and Neck Oncology = Key Concepts from the Seventh THNO Meeting /
LDR:04310nam a22004215i 4500 001 1055136
003 DE-He213
005 20210819235017.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030632342 $9 978-3-030-63234-2
024 7 $a 10.1007/978-3-030-63234-2 $2 doi
035 $a 978-3-030-63234-2
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Critical Issues in Head and Neck Oncology $h [electronic resource] : $b Key Concepts from the Seventh THNO Meeting / $c edited by Jan B. Vermorken, Volker Budach, C. René Leemans, Jean-Pascal Machiels, Piero Nicolai, Brian O’Sullivan.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a IX, 373 p. 39 illus., 33 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) -- Promising biomarkers for early diagnosis and prognosis prediction in HNS -- Biomarkers to predict radiotherapy toxicity -- Biomarkers for hypoxia, HPVness and proliferation from imaging perspective -- Mechanism of cetuximab resistance and how to overcome it -- The role of liquid biopsy for monitoring disease evolution -- NK cells in immunotherapy: how important are they? -- Biomarkers for immune modulatory treatment in HNSCC -- Primary disease (1) -- Novel approaches in surgical management of HNSCC -- The surgical approach to elderly patients with HNSCC -- The nonsurgical approach to locoregionally advanced HNSCC -- High-dose three-weekly or low-dose weekly cisplatin during radiation, what to prefer? -- Primary disease (2) -- Where and when to use induction chemotherapy? -- Prognostic role of p16/HPV in non-oropharyngeal head and neck cancer -- Is there a role for neoadjuvant targeted and immunotherapies? -- Is there a role for adjuvant targeted and immunotherapies? -- Optimal supportive measures during primary treatment -- Precision Medicine in head and neck cancer: myth or reality -- Recurrent and / or metastatic disease -- Salvage surgery: candidates, safe reconstruction, and results? -- Re-irradiation for local relapses or second primaries: when and how? -- New promising targeted agents in first and second-line settings -- Update of immune therapies in recurrent/metastatic HNSCC -- Special Issue -- Patients with rare head neck cancers: do they need a different approach? .-Nasopharynx cancer -- New epidemiological aspects -- New developments in the management of nasopharyngeal carcinoma -- New drugs for recurrent/metastatic nasopharynx cancer.
506 0 $a Open Access
520 $a This open access book discusses the most current issues in head and neck cancer with a focus on current trends such as biomarkers, precision medicine and immunotherapy. New approaches in the diagnosis such as liquid biopsies and imaging biomarkers to predict radiotherapy toxicity as well as approaches in the surgical management of head and neck cancers are discussed. The book discusses medical and surgical approaches in both primary, recurrent and metastatic disease and also covers approaches for rare head neck cancers. Readers will learn about the latest drug developments and epidemiological aspects in cancers ranging from head and neck squamous cell cancer to nasopharynx cancer. Edited by a team of world leaders in head and neck cancer, this volume serves as an easy reference to the head and neck oncology practitioner and provides a contemporary overview for specialists the field. The chapters are based on the latest data presented at the 7th Trends in Head and Neck Oncology Conference and reflect the most up-to-date information in the field.
650 2 4 $a Surgical Oncology. $3 673742
650 1 4 $a Oncology. $3 593951
650 0 $a Surgical oncology. $3 1254222
650 0 $a Radiotherapy. $3 593952
650 0 $a Oncology . $3 1253469
700 1 $a O’Sullivan, Brian. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1360293
700 1 $a Nicolai, Piero. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 674224
700 1 $a Machiels, Jean-Pascal. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1282660
700 1 $a Leemans, C. René. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1282659
700 1 $a Budach, Volker. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1282658
700 1 $a Vermorken, Jan B. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1211361
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030632335
776 0 8 $i Printed edition: $z 9783030632359
776 0 8 $i Printed edition: $z 9783030632366
856 4 0 $u https://doi.org/10.1007/978-3-030-63234-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
912 $a ZDB-2-SOB
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)